Grifols (GIKLY) Depreciation & Amortization (CF) (2010 - 2020)

Grifols (GIKLY) posted Depreciation & Amortization (CF) of $85.6 million for Q1 2020, down 65.48% quarter-over-quarter from $248.1 million in Q4 2019, and up 1.15% year-on-year from $84.7 million in Q2 2019.

Grifols (GIKLY) Depreciation & Amortization (CF) (2010 - 2020) Analysis & Trends

Grifols (GIKLY) has reported Depreciation & Amortization (CF) for 10 consecutive years, with $85.6 million the latest figure, recorded in Q1 2020.

  • Depreciation & Amortization (CF) for Q1 2020 came in at $85.6 million, up 1.15% year-over-year; the trailing twelve-month figure through Dec 2021 was $85.6 million (down 74.34% YoY), and the FY2025 annual result was $523.8 million, up 11.92% from the prior year.
  • Depreciation & Amortization (CF) was $85.6 million for Q1 2020 at Grifols, down from $248.1 million in the prior quarter.
  • Over five years, Depreciation & Amortization (CF) peaked at $248.1 million in Q4 2019 and troughed at $55.6 million in Q3 2016.
  • Average Depreciation & Amortization (CF) over 5 years is $121.5 million, with a median of $85.1 million recorded in 2019.
  • Year-over-year, Depreciation & Amortization (CF) soared 30.64% in 2019 and rose 1.15% in 2020.
  • Over 5 years, Depreciation & Amortization (CF) stood at $55.6 million in 2016, then soared by 235.15% to $186.5 million in 2017, then increased by 1.84% to $189.9 million in 2018, then surged by 30.64% to $248.1 million in 2019, then slumped by 65.48% to $85.6 million in 2020.
  • Per Business Quant data, the three most recent Depreciation & Amortization (CF) figures were $85.6 million in Q1 2020, $248.1 million in Q4 2019, and $84.7 million in Q1 2019.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Dep. & Amort. (Qtr)
1 Eli Lilly 1,066.16 Bn 1,060.88 Bn 16.22 Bn 509.00 Mn
2 Johnson & Johnson 611.69 Bn 589.64 Bn 15.96 Bn 2.00 Bn
3 AbbVie 444.34 Bn 434.99 Bn 10.78 Bn 188.00 Mn
4 Astrazeneca 284.94 Bn 277.05 Bn 12.61 Bn 1.37 Bn
5 Merck 224.23 Bn 218.58 Bn 12.09 Bn 581.00 Mn
6 Amgen 195.12 Bn 183.08 Bn 5.87 Bn 1.12 Bn
7 Gilead Sciences 156.45 Bn 148.73 Bn 5.52 Bn 93.00 Mn
8 Pfizer 136.01 Bn 123.24 Bn -1.21 Bn 1.61 Bn
9 Novartis Ag 113.45 Bn 113.67 Bn - -
10 Grifols - - - -

Historic Data

Download Data
DateValue
Mar 31, 2020 85.64 Mn
Mar 31, 2020 85.64 Mn
Dec 31, 2019 248.08 Mn
Dec 31, 2019 248.08 Mn
Mar 31, 2019 84.66 Mn
Mar 31, 2019 84.66 Mn
Dec 31, 2018 189.89 Mn
Dec 31, 2018 189.89 Mn
Jun 30, 2018 65.73 Mn
Jun 30, 2018 65.73 Mn
Mar 31, 2018 64.97 Mn
Mar 31, 2018 64.97 Mn
Dec 31, 2017 186.46 Mn
Dec 31, 2017 186.46 Mn
Jun 30, 2017 58.53 Mn
Jun 30, 2017 58.53 Mn
Mar 31, 2017 56.80 Mn
Mar 31, 2017 56.80 Mn
Dec 31, 2016 55.19 Mn
Dec 31, 2016 55.19 Mn